Innate Pharma SA (IPHA)
3.02
+1.47
(+94.84%)
USD |
NASDAQ |
Dec 13, 16:00
2.48
-0.54
(-17.88%)
Pre-Market: 08:57
Innate Pharma Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | -142.3% |
| Genfit SA | -- |
| Inventiva SA | -- |
| Nanobiotix SA | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -72.79% |
| Return on Assets | -18.89% |
| Return on Invested Capital | -39.78% |
| Return on Net Operating Assets | -66.42% |